Point-of-Care Diagnostics Market Trends, Growth Drivers, Top Companies Analysis and Forecast to 2027

PRESS RELEASE
Published April 24, 2023

IMARC Group has recently released a new research study titled "Point-of-Care Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

How big is the point-of-care diagnostics market?

The global point-of-care diagnostics market size reached US$ 41.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 69.4 Billion by 2027, exhibiting a growth rate (CAGR) of 9.06% during 2022-2027.

What is point-of-care diagnostics?

Point-of-care (PoC) diagnostics represent the medical testing conducted to analyze several diseases and obtain immediate results. PoC testing usually involves the use of various portable instruments, disposable kits, reusable handheld devices, multifunctional benchtop devices, etc. They aid in the early detection of critical illnesses, thereby simplifying procedures and processes and providing an enhanced patient-centric approach to healthcare. Presently, point-of-care testing essentials are extensively integrated with medical vehicles, including helicopters, air ambulances, airplanes, spacecraft, etc.

Point-of-Care Diagnostics Market Report 


Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

Request to Get the FREE PDF Sample Report: https://www.imarcgroup.com/point-of-care-diagnostics-market/requestsample

Point-of-Care Diagnostics Market Trends:

The growing prevalence of chronic diseases, which lead to increased morbidity and mortality rates, is one of the key factors augmenting the point-of-care diagnostics market. Additionally, the expanding geriatric population and the rising incidences of infectious diseases, such as human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), dengue fever, malaria, influenza, etc., which require timely diagnosis and rapid screening are further catalyzing the market growth. Besides this, healthcare professionals can maintain electronic medical records (EMR) and provide more personalized intervention to patients, on account of the development of miniaturized devices and the increasing integration of wireless technology with PoC diagnostics, thereby positively influencing the global market.

Moreover, these records enable the direct transmission of test results from point-of-care devices to a specialist in the lab, thereby reducing the chances of discrepancies in the obtained test results. Apart from this, extensive R&D activities to introduce molecular diagnostic equipment are acting as significant growth-inducing factors. Furthermore, the escalating demand for home-testing cancer kits, which can actively monitor and analyze tumor cells, is anticipated to fuel the point-of-care diagnostics market over the forecasted period.

Top point-of-care Diagnostics companies covered: 

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Hoffmann-La Roche AG
  • Instrumentation Laboratory
  • Johnson & Johnson
  • Nova Biomedical Corporation
  • Pts Diagnostics
  • Qiagen
  • Siemens
  • Trinity Biotech

Point-of-Care Diagnostics Market Segmentation: 

The report has segmented the market into the following categories:

Breakup by Product Type:

  • Blood-Glucose Monitoring Kit
  • Cardio-Metabolic Monitoring Kit
  • Pregnancy and Fertility Testing Kit
  • Infectious Disease Testing Kit
  • Cholesterol Test Strip
  • Hematology Testing Kit
  • Others

Breakup by Platform:

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays

Breakup by Prescription Mode:

  • Prescription-Based Testing
  • OTC Testing

Breakup by End-User:

  • Professional Diagnostic Centers
  • Home Care
  • Research Laboratories
  • Others

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa 

Speak to Analyst: https://www.imarcgroup.com/request?type=report&id=2113&flag=C

Key Highlights of the Report:                                                    

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

More Related Reports:

https://www.digitaljournal.com/pr/news/hospital-acquired-disease-testing-market-size-to-hit-us-27-7-billion-by-2028-cagr-17-57-

https://www.digitaljournal.com/pr/news/pet-cancer-therapeutics-market-worth-us-473-1-million-by-2028-exclusive-business-report-by-imarc-group

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com
Read Newsletter:
https://www.linkedin.com/newsletters/industry-news-about-6929400456628637696

IMARC